MNKD
MannKind CorporationNASDAQHealthcare$2.50-1.57%ClosedMarket Cap: $770.3M
As of 2026-04-06
Valuation
P/E (TTM)
131.37
PEG
—
P/B
-15.34
P/S
2.26
EV/EBITDA
22.83
DCF Value
$-47.00
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.4%
Operating Margin
11.1%
Net Margin
1.7%
ROE
-11.2%
ROA
0.7%
ROIC
5.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $112.0M | 78.5% | $-7.7M | $-15.9M | $-0.05 | — |
| FY 2025 | $349.0M | 82.5% | $38.8M | $5.9M | $0.02 | — |
| Q3 2025 | $82.1M | 75.4% | $18.8M | $8.0M | $0.03 | — |
| Q2 2025 | $76.5M | 73.1% | $5.3M | $668.0K | $0.00 | — |
| Q1 2025 | $78.4M | 77.6% | $22.3M | $13.2M | $0.04 | — |
| Q4 2024 | $76.8M | 74.5% | $26.5M | $7.4M | $0.03 | — |
| FY 2024 | $285.5M | 73.2% | $72.6M | $27.6M | $0.10 | — |
| Q3 2024 | $70.1M | 74.3% | $12.8M | $11.6M | $0.04 | — |
| Q2 2024 | $72.4M | 71.8% | $16.6M | $-2.0M | $-0.01 | — |
| Q1 2024 | $66.3M | 71.9% | $16.7M | $10.6M | $0.03 | — |
| Q4 2023 | $58.5M | 69.1% | $7.9M | $1.4M | $0.00 | — |
| FY 2023 | $199.0M | 68.5% | $8.7M | $-11.9M | $-0.04 | — |